QUANTITATION OF CIS-DIAMMINEDICHLOROPLATINUM-II (CISPLATIN)-DNA-INTRASTRAND ADDUCTS IN TESTICULAR AND OVARIAN-CANCER PATIENTS RECEIVING CISPLATIN CHEMOTHERAPY

被引：159

作者：

REED, E

YUSPA, SH

ZWELLING, LA

OZOLS, RF

POIRIER, MC

机构：

[1] NCI,DIV CANC TREATMENT,CELLULAR CARCINOGENESIS & TUMOR PROMOT LAB,MED BRANCH,DCE,BLDG 37,BETHESDA,MD 20205

[2] NCI,MOLEC PHARMACOL LAB,BETHESDA,MD 20205

来源：

JOURNAL OF CLINICAL INVESTIGATION | 1986年 / 77卷 / 02期

关键词：

D O I：

10.1172/JCI112335

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：545 / 550

页数：6

共 33 条

[1]

ARMITAGE P, 1971, STATISTICAL METHODS

[2] THIOUREA PREVENTS CYTO-TOXICITY AND MUTAGENICITY, BUT NOT SISTER-CHROMATED EXCHANGES IN V79 CELLS TREATED WITH CIS-DIAMINEDICHLOROPLATINUM(II) [J].

BRADLEY, MO ;

PATTERSON, S ;

ZWELLING, LA .

MUTATION RESEARCH, 1982, 96 (01) :67-74

[3]

CASPER ES, 1979, CANCER TREAT REP, V63, P2023

[4]

CRADDOCK CG, 1977, HEMATOLOGY, P920

[5] KINETIC STUDIES OF CR-51 AND DF-P-32 LABELED GRANULOCYTES [J].

DRESCH, C ;

NAJEAN, Y ;

BAUCHET, J .

BRITISH JOURNAL OF HAEMATOLOGY, 1975, 29 (01) :67-80

[6]

EASTMAN A, 1984, P AM ASSOC CANC RES, V25, P367

[7]

EHRLICH CE, 1979, CANCER TREAT REP, V63, P281

[8] CIS-DIAMMINEDICHLOROPLATINUM, VINBLASTINE, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN DISSEMINATED TESTICULAR CANCER [J].

EINHORN, LH ;

DONOHUE, J .

ANNALS OF INTERNAL MEDICINE, 1977, 87 (03) :293-298

[9]

FLAMM WG, 1969, SUBCELLULAR COMPONEN, P129

[10]

Friedberg E. C., 1981, DNA REPAIR LAB MANUA, P379

← 1 2 3 4 →